Diagnostic approach to microangiopathic hemolytic disorders
نویسندگان
چکیده
منابع مشابه
About Microangiopathic Hemolytic Anemia
To the Editor, I have read with interest the extensive review article by Yenerel on atypical hemolytic uremic syndrome (aHUS) in a recent issue of this journal [1]. I would like to bring to attention the point that more recently some authors do not use the term ‘aHUS’, which was historically used to distinguish heterogeneous, uncharacterized syndromes from Shiga toxin-related HUS (ST-HUS), sinc...
متن کاملCancer-Related Microangiopathic Hemolytic Anemia
Cancer-related microangiopathic hemolytic anemia (CRMAHA) is a paraneoplastic syndrome characterized by Coombs-negative hemolytic anemia with schistocytes and thrombocytopenia. We reviewed and analyzed all cases of CR-MAHA reported since 1979 (the time of the last published review on this topic) according to predefined criteria. We found 154 cases associated with solid cancer and 14 with lympho...
متن کاملThrombotic Microangiopathic Hemolytic Anemia without Evidence of Hemolytic Uremic Syndrome
Because of Yeneral’s extensive review [2] on atypical hemolytic uremic syndrome (aHUS) published recently in the Turkish Journal of Hematology, I brought it to readers’ attention that more recently some authors do not use ‘aHUS’, which was historically used to distinguish heterogeneous uncharacterized syndromes from Shiga toxin-related HUS, since the term lacks both specificity and suggested ca...
متن کاملDiagnostic approach to hemolytic anemias in the adult
Even though hemolytic anemias (HAs) are not very common, their diagnosis remains a big challenge for hematologists and clinicians. We hope that this summary will contribute with valuable information about a subject that has been little described in the medical literature, and will help to clarify the diagnostic approach to guide specific treatment depending on the causative condition. It is kno...
متن کاملDiagnostic approach to primary immunodeficiency disorders.
Primary immunodeficiency disorders (PIDs) are a heterogeneous group of inherited disorders that affect different components of the immune system. There are more than 150 different disorders which have been described till date. Despite major advances in the molecular characterization of PIDs over the last 20 years, many patients remain undiagnosed or are diagnosed too late with severe consequenc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Laboratory Hematology
سال: 2017
ISSN: 1751-5521
DOI: 10.1111/ijlh.12671